Email This Article

Headlines & Perspectives
Vertex Cystic Fibrosis Drug a Game-Changer
By Adam Feuerstein
10/16/08 - 10:50 AM EDT
Vertex Pharmaceuticals' VX-770 attempts to address the underlying causes of the disease. New data from a late-stage trial is expected soon.
Recipient's Email Address(es)
(Separate multiple addresses with a comma)
Your Email Address
Send a copy to myself
Your Message (optional)

Privacy Policy

The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.

Dow Jones S&P 500 NASDAQ 10-Year Note
10,449.28 1,109.72 2,193.28 33.69
Oil *
78.33
DOWN
3.40
UP
0.48
UP
8.25
UP
0.46
10 Yr
3.37%
SPDR Gold
118.97
-0.03%
+0.04%
+0.38%
+1.38%
Data delayed 20 minutes

Brokerage Partners